answer text |
<p><del class="ministerial">The Department has no plans to make an assessment of the
impact of the medical cannabis industry on the economy or employment levels. The Department
annually publishes data on the impact on the economy and employment of the wider Life
Sciences sector in the <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fcollections%2Fbioscience-and-health-technology-database-annual-reports&data=05%7C01%7CRobert.Reid%40officeforlifesciences.gov.uk%7C52a0f4af72164a3b141608da90ba3996%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637981426767702174%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=xG98g%2B1%2BBzW72DAM8Cpp8i%2FEn2ic5G1qf2ZbOzZsXXU%3D&reserved=0"
target="_blank">Bioscience and health technology sector statistics</a>, and this includes
analysis of the bio-pharmaceuticals sector of which the medical cannabis industry
is an important part.</del></p><p> </p><p><ins class="ministerial">In leading his
independent Review of the Research, Development and Innovation Organisational Landscape,
Sir Paul Nurse has gathered input from members of the Review’s Scoping Group and Sounding
Board, alongside hundreds of organisations in the UK’s RDI landscape. Work is underway
to consider and finalise the Review’s recommendations, which will consider input from
those group members, ahead of the Review’s publication in the coming months.</ins></p>
|
|